Induction and maintenance of procedural sedation in adults: focus on remimazolam injection

References

• Hinkelbein J, Lamperti M, Akeson J, et al. European society of anaesthesiology and european board of anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018 Jan;35(1):6–24.
   PubMed Web of Science ®Google Scholar
• Goudra B, Gouda G, Mohinder P. Recent developments in drugs for GI endoscopy sedation. Dig Dis Sci. 2020 Oct;65(10):2781–2788.
   PubMed Web of Science ®Google Scholar
• Johnson KB. New horizons in sedative hypnotic drug development: fast, clean, and soft. Anesth Analg. 2012 Aug;115(2):220–222.
   PubMed Web of Science ®Google Scholar
• Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019 Jan;155(1):137–146.
   PubMed Web of Science ®Google Scholar
• Wesolowski AM, Zaccagnino MP, Malapero RJ, et al. Remimazolam: pharmacologic Considerations and clinical role in anesthesiology. Pharmacotherapy. 2016 Sep;36(9):1021–1027.
   PubMed Web of Science ®Google Scholar
• Van Haperen M, Preckel B, Eberl S. Indications, contraindications, and safety aspects of procedural sedation. Curr Opin Anaesthesiol. 2019 Dec;32(6):769–775.
   PubMed Web of Science ®Google Scholar
• Bayman EO, Dexter F, Laur JJ, et al. National incidence of use of monitored anesthesia care. Anesthesia Analg. 2011;113(1):165-169.
   Web of Science ®Google Scholar
• Kilpatrick GJ, McIntyre MS, Cox RF, et al., CNS 7056: a novel ultra–short-acting benzodiazepine. Anesthesiology. 2007;107(1): 60–66.
   PubMed Web of Science ®Google Scholar
• Benzoni T, Cascella M,tatPearls [Internet]. Procedural Sedation. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Lamperti M. Adult procedural sedation: an update. Curr Opin Anaesthesiol. 2015 Dec;28(6):662–667.
   PubMed Web of Science ®Google Scholar
• Hinkelbein J, Schmitz J, Lamperti M, et al. Procedural sedation outside the operating room. Curr Opin Anaesthesiol. 2020 Aug;33(4):533–538.
   PubMed Web of Science ®Google Scholar
• Barends CRM, Absalom AR, Struys M. Drug selection for ambulatory procedural sedation. Curr Opin Anaesthesiol. 2018 Dec;31(6):673–678.
   PubMed Web of Science ®Google Scholar
• Knape JTA, Adriaensen H, Van Aken H, et al. Guidelines for sedation and/or analgesia by non-anaesthesiology doctors: SECTION and BOARD OF ANAESTHESIOLOGY1, European union of medical specialists. European Journal of Anaesthesiology | EJA. 2007;24(7):563–567.
   PubMed Web of Science ®Google Scholar
• Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244–251.
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists. Continuum of depth of sedation: definition of general anesthesia and levels of sedation/analgesia cited 2020 Dec 25. Available from: https://www.asahq.org/~/media/sites/asahq/files/public/resources/standards-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedation-analgesia.pdf
   Google Scholar
• Kochhar GS, Gill A, Vargo JJ. On the horizon: the future of procedural sedation. Gastrointest Endosc Clin N Am. 2016 Jul;26(3):577–592.
   PubMedGoogle Scholar
• Edwards JA, Kinsella J, Shaw A, et al. Sedation for oocyte retrieval using target controlled infusion of propofol and incremental alfentanil delivered by non-anaesthetists. Anaesthesia. 2010;65(5):453–461.
   PubMed Web of Science ®Google Scholar
• Hannam JA, Borrat X, Trocóniz IF, et al. Modeling respiratory depression induced by remifentanil and propofol during sedation and analgesia using a continuous noninvasive measurement of pCO2. J Pharmacol Exp Ther. 2016;356(3):563–573.
   PubMed Web of Science ®Google Scholar
• Goudra BG, Singh PM. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014 Jul;8(3):388–391.
   PubMedGoogle Scholar
• Eger EI. Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health Syst Pharm. 2004;61(suppl_4):S3–10.
   PubMedGoogle Scholar
• Eleveld DJ. Propofol PK-PD. In: Absalom AR, Mason KP, editors. Total intravenous anesthesia and target controlled infusions: a comprehensive global anthology. Cham: Springer International Publishing; 2017. p. 191–208.
   Google Scholar
• Vuyk J, Sitsen E, Reekers M, et al. Intravenous Anesthetics. In: Gropper M, Eriksson L, Fleisher Leditors. Miller’s Anesthesia. Philadelphia, PA: Elsevier; 2020. p. 638–679.
   Google Scholar
• Bouillon T, Bruhn J, Radu-Radulescu L, et al. Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady state. Anesthesiology. 2004;100(2):240–250.
   PubMed Web of Science ®Google Scholar
• DIPRIVAN (propofol) injectable emulsion, USP [cited 2021 Feb 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019627s066lbl.pdf
   Google Scholar
• Jalota L, Kalira V, George E, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011 Mar;15:342. d1110.
   Google Scholar
• Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth. 2012 Mar;108(3):460–468.
   PubMed Web of Science ®Google Scholar
• Michelsen LG, Hug CC, Jr HC. The pharmacokinetics of remifentanil. J Clin Anesth. 1996;8(8):679–682.
   PubMed Web of Science ®Google Scholar
• Sheng X-Y, Liang Y, Yang X-Y, et al. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur J Clin Pharmacol. 2020;76(3):383–391.
   PubMed Web of Science ®Google Scholar
• Reves JG, Fragen Robert J, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology. 1985;62(3):310–324.
   PubMed Web of Science ®Google Scholar
• Biebuyck Julien F, Smith I, White Paul F, et al. Propofol: an update on its clinical use. Anesthesiology. 1994;81(4):1005–1043.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Kou TD, Rex DK. Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med. 2013;173(7):551–556.
   PubMed Web of Science ®Google Scholar
• Sneyd JR. Remimazolam: new beginnings or just a me-too? Anesth Analg. 2012 Aug;115(2):217–219.
   PubMed Web of Science ®Google Scholar
• Mandona JW, Tuk B, Van Steveninck AL, et al. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther. 1992;51(6):715–728.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984;61(1):27-35.
   PubMed Web of Science ®Google Scholar
• Albrecht S, Ihmsen H, Hering W, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999;65(6):630–639.
   PubMed Web of Science ®Google Scholar
• Kisilewicz M, Rosenberg H, Vaillancourt C. Remifentanil for procedural sedation: a systematic review of the literature. Emer Med J. 2017;34(5):294–301.
   PubMed Web of Science ®Google Scholar
• Sneyd JR. Remifentanil manual versus target-controlled infusion. Anesthesia Analg. 2003;97(1):300.
   PubMed Web of Science ®Google Scholar
• Moerman AT, Herregods LL, De Vos MM, et al. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesthesia Analg. 2009;108(3):828–834.
   PubMed Web of Science ®Google Scholar
• Bailey PL, Pace NL, Ashburn MA, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology. 1990;73(5):826.
   PubMed Web of Science ®Google Scholar
• Lapierre CD, Johnson KB, Randall BR, et al. An exploration of remifentanil-propofol combinations that lead to a loss of response to esophageal instrumentation, a loss of responsiveness, and/or onset of intolerable ventilatory depression. Anesthesia & Analgesia. 2011;113.
   Google Scholar
• Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370–380.
   PubMed Web of Science ®Google Scholar
• Kamp J, Olofsen E, Henthorn TK, et al. Ketamine Pharmacokinetics. Anesthesiology. 2020 Dec 1;133(6):1192–1213.
   PubMedGoogle Scholar
• Goudra B, Singh P. Propofol alternatives in gastrointestinal endoscopy anesthesia [review article].Saudi J Anaesth. 2014 [Oct 1];8(4):540–545.
   PubMedGoogle Scholar
• Paul R, Schaaff N, Padberg F, et al. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases. World J Biol Psychiatry. 2009;10(3):241–244.
   PubMed Web of Science ®Google Scholar
• Jalili M, Bahreini M, Irani AD, et al. Ketamine-propofol combination (ketofol) vs propofol for procedural sedation and analgesia: systematic review and meta-analysis. Am J Emerg Med. 2016;34(3):558–569.
   PubMed Web of Science ®Google Scholar
• Weerink MAS, Struys M, Hannivoort LN, et al. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017 Aug;56(8):893–913.
   PubMed Web of Science ®Google Scholar
• Barends CR, Absalom A, Van Minnen B, et al. Dexmedetomidine versus Midazolam in procedural sedation. A systematic review of efficacy and safety. PLoS One. 2017;12(1):e0169525.
   PubMed Web of Science ®Google Scholar
• Slupe AM, Minnier J, Raitt MH, et al. Dexmedetomidine sedation for paroxysmal supraventricular tachycardia ablation is not associated with alteration of arrhythmia inducibility. Anesthesia Analg. 2019;129(6):1529–1535.
   PubMed Web of Science ®Google Scholar
• Colin PJ, Hannivoort LN, Eleveld DJ, et al. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile. Br J Anaesth. 2017 Aug 1;119(2):211–220.
   PubMed Web of Science ®Google Scholar
• Raeder J. Procedural sedation in ambulatory anaesthesia: what’s new? Curr Opin Anaesthesiol. 2019 Dec;32(6):743–748.
   PubMed Web of Science ®Google Scholar
• Freyer N, Knospel F, Damm G, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019;13:1033–1047.
   PubMed Web of Science ®Google Scholar
• Sigel E, Ernst M. The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol Sci. 2018 Jul;39(7):659–671.
   PubMed Web of Science ®Google Scholar
• Barnard EA, Skolnick P, Olsen RW, et al. International union of pharmacology. xv. subtypes of γ-aminobutyric acida receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev. 1998;50(2):291–314.
   PubMed Web of Science ®Google Scholar
• Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012 Aug;115(2):274–283.
   PubMed Web of Science ®Google Scholar
• Wiltshire HR, Kilpatrick GJ, Tilbrook GS, et al., A placebo- and midazolam-controlled phase i single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056). Anesthesia Analg. 115(2): 284–296. 2012.
   PubMed Web of Science ®Google Scholar
• Schuttler J, Eisenried A, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020 Apr;132(4):636–651.
   PubMedGoogle Scholar
• Eisenried A, Schüttler J, Lerch M, et al., Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. pharmacodynamics of electroencephalogram effects. Anesthesiology. 132(4): 652–666. 2020.
   PubMedGoogle Scholar
• Lohmer LL, Schippers F, Petersen KU, et al. Time-to-event modeling for remimazolam for the indication of induction and maintenance of general anesthesia. J Clin Pharmacol. 2020 Apr;60(4):505–514.
   PubMed Web of Science ®Google Scholar
• About Remimazolam [cited 2020 Dec 25]. Available from: https://www.paion.com/remimazolam/indikationen/leitsubstanz-remimazolam/
   Google Scholar
• Zhou Y, Hu P, Huang Y, et al. Population pharmacokinetic/pharmacodynamic model-guided dosing optimization of a novel sedative HR7056 in chinese healthy subjects. Front Pharmacol. 2018;9:1316.
   PubMed Web of Science ®Google Scholar
• Chen X, Sang N, Song K, et al. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote. Clin Ther. 2020 Apr;42(4):614–624.
   PubMed Web of Science ®Google Scholar
• Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020 Aug;33(4):506–511.
   PubMed Web of Science ®Google Scholar
• Rastogi A, Wani S. Colonoscopy. Gastrointest Endosc. 2017 Jan;85(1):59–66.
   PubMed Web of Science ®Google Scholar
• Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol. 2006;101(5):967.
   PubMed Web of Science ®Google Scholar
• Wang D, Chen C, Chen J, et al. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS One. 2013;8(1):e53311.
   PubMed Web of Science ®Google Scholar
• Sneyd JR, Rigby-Jones AE. New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth. 2010 Sep;105(3):246–254.
   PubMed Web of Science ®Google Scholar
• Worthington MT, Antonik LJ, Goldwater DR, et al. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013 Nov;117(5):1093–1100.
   PubMed Web of Science ®Google Scholar
• Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018 Sep;88(3):427–437 e6.
   PubMed Web of Science ®Google Scholar
• Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016 May;83(5):984–992.
   PubMed Web of Science ®Google Scholar
• Rex DK, Bhandari R, Lorch DG, et al. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021 Jan;53(1):94-101. • Large phase III study of remimazolam in high-risk colonoscopy.
   Google Scholar
• Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594–4603.
   PubMed Web of Science ®Google Scholar
• Vicari JJ. Sedation in the ambulatory endoscopy center: optimizing safety, expectations and throughput. Gastrointest Endosc Clin N Am. 2016 Jul;26(3):539–552.
   PubMedGoogle Scholar
• Levy I, Gralnek IM. Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopy. Best Pract Res Clin Gastroenterol. 2016 Oct;30(5):705–718.
   PubMed Web of Science ®Google Scholar
• Borkett KM, Riff DS, Schwartz HI, et al. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015 Apr;120(4):771–780.
   PubMed Web of Science ®Google Scholar
• Chen SH, Yuan TM, Zhang J, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2020 Jul 17;36(2):474–481.
   Web of Science ®Google Scholar
• McCambridge AJ, Boesch RP, Mullon JJ. Sedation in bronchoscopy: a review. Clin Chest Med. 2018 Mar;39(1):65–77.
   PubMed Web of Science ®Google Scholar
• De Lima A, Kheir F, Majid A, et al. Anesthesia for interventional pulmonology procedures: a review of advanced diagnostic and therapeutic bronchoscopy. Can J Anaesth. 2018 Jul;65(7):822–836.
   PubMed Web of Science ®Google Scholar
• Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american College of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):E211–E250.
   Web of Science ®Google Scholar
• Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010 Jan 15;181(2):116–124.
   PubMed Web of Science ®Google Scholar
• Wahidi MM, Jain P, Jantz M, et al. American college of chest physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest. 2011;140(5):1342–1350.
   PubMed Web of Science ®Google Scholar
• Du Rand IA, Barber PV, Goldring J, et al. British thoracic society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax. 2011;66(Suppl3):iii1–iii21.
   PubMedGoogle Scholar
• Kern M, Kerner T, Tank S. Sedation for advanced procedures in the bronchoscopy suite: proceduralist or anesthesiologist? Curr Opin Anesthesiol. 2017;30(4):490–495.
   PubMed Web of Science ®Google Scholar
• Patatas K, Koukkoulli A. The use of sedation in the radiology department. Clin Radiol. 2009;64(7):655–663.
   PubMed Web of Science ®Google Scholar
• Martin ML, Lennox PH. Sedation and analgesia in the interventional radiology department. Journal of Vascular & Interventional Radiology. 2003;14(9):1119–1128.
   PubMed Web of Science ®Google Scholar
• Whitehead NJ, Clark AL, Williams TD, et al. Sedation and analgesia for cardiac catheterisation and coronary intervention. Heart Lung Circ. 2020 Feb;29(2):169–177.
   PubMed Web of Science ®Google Scholar
• Lavi S, Jolly SS, Bainbridge D, et al. Sedation, analgesia, and anaesthesia variability in laboratory-based cardiac procedures: an international survey. Can J Cardiol. 2014 Jun;30(6):627–633.
   PubMed Web of Science ®Google Scholar
• Thomas SP, Thakkar J, Kovoor P, et al. CSANZ position statement on sedation for cardiovascular procedures (2014). Heart Lung Circ. 2015 Nov;24(11):1041–1048.
   PubMed Web of Science ®Google Scholar
• Drug Approval Package: BYFAVO [cited 2020 Dec 25]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/212295Orig1s000TOC.cfm
   Google Scholar
• Midazolam - Food and Drug Administration [cited 2021 Feb 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208878Orig1s000lbl.pdf
   Google Scholar
• Schippers F, Pesic M, Saunders R, et al. Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users. J Clin Pharmacol. 2020 Sep;60(9):1189–1197.
   PubMed Web of Science ®Google Scholar
• Inouye SK. Delirium in Older Persons. N Engl J Med. 2006;354(11):1157–1165.
   PubMed Web of Science ®Google Scholar
• Struys MM, De Smet T, Glen JI, et al. The history of target-controlled infusion. Anesth Analg. 2016 Jan;122(1):56–69.
   PubMed Web of Science ®Google Scholar
• Absalom AR, Glen JB, Zwart GJC, et al. Target-controlled infusion: a mature technology. Anesthesia Analg. 2016;122(1):70–78.
   PubMed Web of Science ®Google Scholar
• Engbers FHM, Dahan A. Anomalies in target-controlled infusion: an analysis after 20 years of clinical use. Anaesthesia. 2018;73(5):619–630.
   PubMed Web of Science ®Google Scholar
• Zhou J, Curd L, Lohmer LL, et al. Population pharmacokinetics of remimazolam in procedural sedation with nonhomogeneously mixed arterial and venous concentrations. Clinical and Translational Science. 2021;14(1):326-334.
   Google Scholar
• Zhou J, Leonowens C, Ivaturi VD, et al. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020 Nov;66:109899.
   PubMed Web of Science ®Google Scholar
• Steib A, Freys G, Jochum D. et al. Recovery from total intravenous anaesthesia. Propofol versus midazolam-flumazenil. 1990;34( 8):632–635.
   Google Scholar
• Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020 Aug;34(4):543–553.
   PubMed Web of Science ®Google Scholar
• Doi M, Hirata N, Suzuki T, et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020 Aug;34(4):491–501.
   PubMed Web of Science ®Google Scholar
• Koers L, Eberl S, Cappon A, et al. Safety of moderate-to-deep sedation performed by sedation practitioners: a national prospective observational study. European Journal of Anaesthesiology | EJA. 2018;35(9):659–666.
   PubMed Web of Science ®Google Scholar
• Kleiman RB, Darpo B, Thorn M, et al. Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. Br J Clin Pharmacol. 2020;86(8):1600–1609.
   PubMed Web of Science ®Google Scholar
• Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008 Jul;90(1):74–89.
   PubMed Web of Science ®Google Scholar
• Kallman MJ. Preclinical abuse potential assessment. In: Pugsley MK, Curtis MJ, editors. Principles of safety pharmacology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 115–130.
   Google Scholar
• Remimazolam Besylate receives marketing approval for Ruima® by National Medical Products Administration [cited 2020 Dec 25]. Available from: https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20200720150401375.html
   Google Scholar
• Remimazolam Tosylate receives marketing approval for Ruibeining® by National Medical Products Administration [cited 2020 Dec 25]. Available from: https://www.nmpa.gov.cn/directory/web/nmpa/yaowen/ypjgyw/20191227191701982.html
   Google Scholar
• Keam SJ. Remimazolam: first Approval. Drugs. 2020 Apr;80(6):625–633.
   PubMed Web of Science ®Google Scholar
• Chawla N, Boateng A, Deshpande R. Procedural sedation in the ICU and emergency department. Curr Opin Anesthesiol. 2017;30(4):507–512.
   PubMed Web of Science ®Google Scholar
• Dingemanse J, Van Gerven JMA, Schoemaker RC, et al. Integrated pharmacokinetics and pharmacodynamics of Ro 48–6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. Br J Clin Pharmacol. 1997;44(5):477–486.
   PubMed Web of Science ®Google Scholar
• Van Gerven JMA, Roncari G, Schoemaker RC, et al. Integrated pharmacokinetics and pharmacodynamics of Ro 48–8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. Br J Clin Pharmacol. 1997;44(5):487–493.
   PubMed Web of Science ®Google Scholar
• Upton RN, Martinez AM, Grant C. A dose escalation study in sheep of the effects of the benzodiazepine CNS 7056 on sedation, the EEG and the respiratory and cardiovascular systems. Br J Phar macol.2008;155(1):52–61.
   PubMed Web of Science ®Google Scholar
• Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology. 2009 Oct;137(4):1229–1237. quiz 1518-9.
   PubMed Web of Science ®Google Scholar